Tibial stress fractures are among the most common overuse injuries affecting military personnel, but they can be difficult to identify in their earliest stages. Small stresses in the bone may develop before an injury becomes apparent through conventional diagnostic tools, creating a window of opportunity for earlier detection to enable intervention.
Our sense of smell is crucial to perceiving the world around us; it’s linked to memories and can even affect emotions. However, our sense of smell remains one of the last frontiers to be digitally recreated. Unlike vision and sound, which can now be easily reproduced by all types of devices in our homes, smell cannot yet be digitally reproduced to let us experience the delicious casserole from a cooking show or the musky forest floor from a nature documentary.
Scientists at Trinity College Dublin have made a breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a “zombie-like state,” called premature senescence, that can attract the wound-healing properties of the immune system.
What if we could use a cancer’s own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.
In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each patient’s own tumor, to pembrolizumab immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%.
An overlooked mechanism in lung cancer tumors may help explain why most patients don’t respond to immunotherapy, according to new research led by Olga Anczuków, professor at The Jackson Laboratory for Genomic Medicine in Farmington, Connecticut, and deputy director of the NCI-designated Jackson Laboratory Cancer Center.
Type 2 diabetes is becoming increasingly common worldwide. Unlike type 1 diabetes, it is often linked to obesity, a sedentary lifestyle and excess energy intake over many years. Although insulin injections can bring blood sugar levels down, they do not address the body’s chronic energy surplus. Insulin merely helps muscle cells take up glucose from the bloodstream, but if the body does not use that energy, the excess is converted into fat. This helps explain why many patients continue to gain weight despite treatment.
SEOUL, South Korea and CHICAGO, Oct. 23, 2026 /PRNewswire/ — Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta Metrics, its AI-powered aortic quantitative analysis software. The clearance, received on October 16, brings the company’s total to 13 FDA 510(k) clearances.
PLAINSBORO, N.J., Oct. 23, 2026 /PRNewswire/ — Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first once-weekly, long-acting basal insulin, as an adjunct to diet and exercise to improve glycemic control (blood sugar) in children 10 years of age and older with type 2 diabetes.1 This approval offers a once-weekly basal insulin treatment option, which reduces the frequency of weekly basal injections from seven to one per week.1
After obtaining U.S. and European approvals this summer, Enable Injections has claimed its first regulatory green light in Japan for its enFuse wearable drug delivery technology.